Saturday 17 October 2026
Export RNAZ’s income statement to Excel — free account
TransCode Therapeutics Inc.
RNAZ Healthcare Biotechnology
In the quarter to June 2026, EPS fell 39.8% and free cash flow fell 28.8%, each against the same quarter a year earlier.
1.70
0.10
−5.56%
Follow RNAZ
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+8 more quarters Free account |
2.84 | 17.81 | 12.84 | 8.38 |
Receivables |
0.20 | 0.95 | 0.00 | 0.00 | |
Other current assets |
— | 2.30 | 2.30 | — | |
Total current assets |
4.75 | 21.98 | 16.75 | 10.64 | |
Property, Plant, Equpment (Net) |
0.02 | 0.37 | 0.35 | 0.32 | |
Goodwill and Intangible Assets (Total) |
— | 140.04 | 140.04 | 140.04 | |
Total non-current assets |
0.48 | 140.41 | 140.42 | 140.37 | |
Total Assets |
5.23 | 162.40 | 157.16 | 151.01 | |
Notes Payable |
— | — | — | 0.65 | |
Accounts Payable |
2.97 | 3.49 | 5.29 | 4.68 | |
Current Revenue (Deferred) |
0.00 | — | 0.09 | 0.06 | |
Total current liabilities |
2.97 | 3.49 | 5.38 | 5.40 | |
Long Term Tax Liability (Deferred) |
— | 0.23 | 0.46 | 0.46 | |
Preferred Shares of Subsidiary (Mandatory, Redeemable) |
— | 141.54 | 143.27 | 166.05 | |
Non-current Liabilities (Other) |
0.83 | 6.80 | 6.81 | 6.80 | |
Total non-current liabilities |
0.83 | 148.57 | 150.53 | 173.31 | |
Total liabilities |
3.80 | 152.06 | 155.91 | 178.71 | |
Additional Paid In Capital |
85.85 | 108.20 | 116.90 | 94.70 | |
Preferred Stock (Total) |
— | — | 0.00 | 0.00 | |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.00 | |
Retained Earnings |
(84.42) | (97.86) | (115.65) | (122.40) | |
Common Equity (Total) |
1.43 | 10.34 | 1.25 | (27.70) | |
Shareholders Equity (Total) |
1.43 | 10.34 | 1.25 | (27.69) | |
Shareholders Equity and Liabilities (Total) |
5.23 | 162.40 | 157.16 | 151.01 | |
Shares (Common) |
0.83 | 0.92 | 0.92 | 1.01 | |
Shareholders Equity (Tangible) |
1.43 | (129.71) | (138.79) | (167.74) | |
Net Debt |
(2.84) | (17.81) | (12.84) | (8.38) |
In millions of $ except per-share values · columns are period end dates